OECD Guidelines for Acute Inhalation Toxicity: The Right Testing Strategy Using TG 403, TG 433, and TG 436
The respiratory tract is one of the fastest and most critical routes of exposure to chemical substances. Determining inhalation toxicity—particularly for industrial chemicals in the form of volatile organic compounds, aerosols, gases, dusts, and fumes—is of vital importance for both worker health and consumer safety. Our laboratory offers GLP-compliant, ethical, and scientific solutions in the field of acute inhalation toxicity using the three fundamental test guidelines established by the OECD: TG 403, TG 433, and TG 436. So, what are the differences between these three guidelines, and which one is the most suitable choice for your product?
OECD TG 403: Classic Acute Inhalation Toxicity Test
OECD TG 403 is the traditional protocol used to determine acute inhalation toxicity. In this method, test animals are exposed to a test substance at a specific concentration for 4 hours, after which clinical signs, changes in body weight, mortality, and necropsy findings are recorded during an observation period of at least 14 days. The primary outcome of the test is the LC50 value (expressed in mg/L, ppm, or mg/m³), calculated based on the concentration of the substance in the inhaled air. TG 403 is preferred particularly when comprehensive dose-response data are required for submission to regulatory agencies and when sufficient information on the substance’s toxicity profile is not yet available.
OECD TG 436: Acute Inhalation Toxicity – Concentration × Time (C×t) Protocol
OECD TG 436 represents a newer and ethically more refined approach compared to TG 403. The most notable difference in this method is the evaluation of toxicity by using different exposure durations (e.g., 1, 2, 4, or 8 hours) at a constant concentration. TG 436 aims to avoid using death as an endpoint; instead, it relies on evident toxicity findings (e.g., severe clinical signs, significant loss of body weight). This allows the concentration-time combination at which the test substance becomes toxic to be determined using fewer animals. TG 436 is ideal for manufacturers who wish to prioritize animal welfare while providing sufficient data, particularly for GHS classification.
OECD TG 433: Acute Inhalation Toxicity – Fixed-Concentration Method
OECD TG 433 is another modern guideline that, like TG 436, emphasizes ethical principles. In this method, the test substance is administered at predetermined fixed concentration levels (e.g., 0.5, 2, 10 mg/L), and the exposure duration is typically kept constant at 4 hours. The primary objective is to define the concentration range that exhibits distinct toxicity, rather than using mortality as an endpoint. TG 433 is an excellent option for the classification and labeling of substances for which preliminary information on toxicity potential is available.
The table below provides a comparative overview of the key features of these three OECD guidelines:
| Feature | OECD TG 403 | OECD TG 433 | OECD TG 436 |
|---|---|---|---|
| Test Design | At least 3 concentration levels, separate groups for each | Fixed concentration levels, a single group per level | Single fixed concentration, different exposure durations |
| Exposure Duration | 4 hours (fixed) | 4 hours (fixed) | Variable (1, 2, 4, or 8 hours) |
| Primary Endpoint | Mortality (LC50 calculation) | Detectable toxicity (mortality secondary) | Detectable toxicity (mortality secondary) |
| Use of Animals | High (typically 20–30 test subjects) | Low (typically 6–12 test subjects) | Low (typically 6–12 test subjects) |
| LC50 Calculation | Yes, with rigorous statistical analysis | No, only the concentration range is determined | No, evaluation based on the C×t relationship |
| 3R Compliance | Moderate | High (Focused on Reduction and Refinement) | High (Focused on Reduction and Refinement) |
| When Preferred | When definitive LC50 data is required, for new substance profiling | When sufficient data is required for GHS classification and labeling | When different exposure scenarios need to be evaluated |
Which OECD Guideline Is Right for You?
Selecting the right testing strategy depends entirely on your product’s use scenario, physicochemical properties, and regulatory objectives. The table below will guide you through your decision-making process:
| Product Characteristic / Requirement | Recommended Guideline | Rationale |
|---|---|---|
| A completely new chemical; no toxicity data available | TG 403 | Provides a comprehensive dose-response profile and precise LC50 data |
| Sufficient data is required for GHS classification; animal use should be minimized | TG 433 | Offers an ethical and economical solution using fixed concentrations |
| The effect of different exposure durations is to be evaluated (emergency scenarios) | TG 436 | Performs toxicity assessment at varying durations using the C×t protocol |
| Particulate matter in the form of aerosols, dust, or smoke | TG 403 or TG 436 | Applied in conjunction with particle size distribution (MMAD) and respirability analysis |
| Volatile substances in the form of gas or vapor | TG 433 or TG 436 | Fixed-concentration methods are more practical for substances in gaseous form |
| Mandatory testing under EU REACH or CLP | TG 433 or TG 436 | European regulations prioritize modern methods compliant with the 3Rs |
Conducting Inhalation Toxicity Tests in Our Laboratory
In our GLP-certified laboratory, while conducting acute inhalation toxicity studies, we continuously monitor critical parameters such as the homogeneity and stability of the exposure atmosphere, as well as the particle size distribution. Using either our nose-only or whole-body exposure systems, we select the application method best suited to the physical form of the test substance. Our experienced team of toxicologists is committed to producing the most reliable scientific data using the fewest possible laboratory animals, adhering to the 3R principles at every stage.
The table below summarizes the quality control parameters we monitor in our inhalation toxicity tests:
| Parameter | Control Frequency | Acceptance Criteria |
|---|---|---|
| Atmospheric concentration (gravimetric/chemical analysis) | At least 3 times during the exposure period | Within ±20% of the target concentration |
| Particle size distribution (MMAD and GSD) | At least once at each concentration level | MMAD: 1–4 µm (inhalable fraction), GSD: 1.5–3.0 |
| Temperature and humidity | Continuous monitoring | Temperature: 22±3°C, Humidity: 30–70% |
| Oxygen level | Periodically at the start of and throughout exposure | ≥19% (to avoid hypoxia) |
| Airflow rate | Continuous monitoring | Adequate ventilation and atmospheric homogeneity must be ensured |
Frequently Asked Questions
| Question | Answer |
|---|---|
| What types of substances should undergo inhalation testing? | All chemicals in the form of gases, vapors, aerosols, dusts, and smoke, as well as liquids that can vaporize at room temperature, require inhalation testing. It is also recommended for any product whose use scenario involves respiratory exposure. |
| Is there a difference in regulatory acceptance between TG 403, 433, and 436? | All three guidelines have been officially adopted by the OECD and are recognized by major regulatory bodies such as EU REACH, CLP, and the EPA. However, modern approaches (TG 433 and TG 436) are primarily recommended by ethics committees and certain regulatory authorities. |
| What data must be provided to the laboratory prior to testing? | The substance’s physicochemical properties (vapor pressure, particle size, explosiveness/flammability), available toxicity data, chemical analysis method, and safety data sheet (SDS) are required. |
| How long do the testing and reporting take? | The exposure and 14-day observation period take approximately 2–3 weeks. Including reporting and quality assurance review, the total duration is typically 6–8 weeks. |
| Can an LC50 value be calculated in TG 433 and TG 436? | These guidelines are primarily based on apparent toxicity and are not designed for a precise LC50 calculation. However, the data obtained provides a sufficient range estimate for GHS classification. |
The respiratory tract is the fastest route of entry for chemicals into the body. To evaluate the risks your product may pose when entering the body through this route in accordance with scientific and ethical standards, contact us at our GLP-certified laboratory. Let’s work together to plan the most appropriate inhalation toxicity testing strategy for your product.